Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update (2019): report user perspectives on TB LAM testing: results from qualitative research

Simple item page
dc.coverageGeneva
dc.creatorEngel, Nora
dc.creatorMwaura, Muthoni
dc.date2019-10-31T08:45:09Z
dc.date2019-10-31T08:45:09Z
dc.date2019-10-31
dc.date.accessioned2026-08-02T20:12:26Z
dc.description14 p.
dc.formatapplication/pdf
dc.identifierWHO/CDS/TB/2019.20
dc.identifierhttps://iris.who.int/handle/10665/329513
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/83855
dc.languageEnglish
dc.languageen
dc.publisherWorld Health Organization
dc.rightsCC BY-NC-SA 3.0 IGO
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/3.0/igo
dc.rightsWorld Health Organization
dc.subjectHIV Infections
dc.subjectTuberculosis
dc.subjectLipopolysaccharides
dc.subjectMolecular Diagnostic Techniques
dc.subjectResearch
dc.titleLateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update (2019): report user perspectives on TB LAM testing: results from qualitative research
dc.typeTechnical Documents

Files

Collections

WHO IRIS